YmAbs Therapeutics, Inc. (NASDAQ:YMAB) Q3 2019 Earnings Conference Call - Final Transcript
Nov 13, 2019 • 04:30 pm ET
are building this organization. I think we had a great Chief Commercial Officer to help with this [Phonetic] and make sure we are ready to launch in due time for our potential approval next year.
Great, thanks very much, and best of luck to you.
There are no further questions in the queue, I'd like to hand the call back to management for closing remarks.
Thanks everyone. I think that concludes it. Thanks Bo, thanks Claus, thank you everyone for dialing in. Have a great evening.
Thanks Thomas, take care.
[Operator Closing Remarks]